PP_1170x120_10-25-21

Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies

J&J to stop selling opioid meds as part of $230M settlement with New York

J&J to stop selling opioid meds as part of $230M settlement with New York

NEW YORK – Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies announced  this weekend a settlement agreement with the State of New York and its participating subdivisions, including Nassau County and Suffolk County, resolving their opioid-related claims against the company. With this agreement, the company is removed from the trial scheduled to begin in